A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine. That was one of the findings reported by a multi-institutional team led by researchers at Washington University School of Medicine in St. Louis.
